NGS Sample Preparation Market - GLOBAL

Key Questions Answered in this Report:

• What are the major market drivers, challenges, and opportunities in the global NGS sample preparation market?
• What are the underlying structures resulting in the emerging trends within the global NGS sample preparation market?
• How is each segment expected to grow in the global NGS sample preparation market during the forecast period and what is the estimated revenue to be generated by each of the segments by the end of 2025?
• What are the key developmental strategies which are implemented by the major players in order to sustain in the competitive market? What are the key regulatory implications in developed and developing regions for NGS sample preparation?
• Who are the leading players with significant offerings to the global NGS sample preparation market? What is the current market dominance for each of these leading players?
• What would be the compound growth rate witnessed by the leading players in the market during the forecast period 2019-2025?
• What are the key applications in global NGS sample preparation market? What are the major segments of these applications?
• Which are the dominant therapeutic areas of the global NGS sample preparation market? Which is the fastest growing therapeutic area in the global NGS sample preparation market?
• Who are the key manufacturers and service providers in the global NGS sample preparation market, and what are their contributions? What is the growth potential of each major NGS sample preparation provider?
• What is the scope of the global NGS sample preparation market in North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa?
Global NGS Sample Preparation Market Forecast, 2019-2025
The NGS sample preparation industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.54% during the forecast period, 2019-2025. The NGS sample preparation market generated $1,140.0 million revenue in 2018, in terms of value.
The NGS sample preparation market growth has been primarily attributed to the major drivers in this market such as rising prevalence of genetic disorders and infectious diseases, increasing direct-to-consumer genetic testing, and increasing research in the field of genomics. However, there are significant challenges which are restraining the market growth. These challenges include cost constraints pertaining to automated NGS sample preparation affecting adoption, lack of high complexity genetic testing centers, and regulatory uncertainty.
Expert Quote
“The development of automated sample preparation equipment and consumables has achieved huge success over the past year with automated workstations and specialized kits now available across major regions proving the potential of these equipment to lower cost and ease sequencing research around the globe.”
Scope of the Market Intelligence on NGS Sample Preparation Market
The NGS sample preparation research provides a holistic view of the market in terms of various factors influencing it, including product optimization, and technological advancements.
The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the market. In addition, the study also includes exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global NGS sample preparation market.
Market Segmentation
The NGS sample preparation market segmentation (on the basis of product) is further segmented into workstations, standalone equipment, consumables, accessories.
The NGS sample preparation market segmentation (on the basis of application) is segmented into DNA sequencing, whole-genome sequencing, RNA sequencing, methylation sequencing, metagenomics, single cell sequencing, and others.
The NGS sample preparation market segmentation (on the basis of therapeutic area) is segmented into oncology, human genetics/population genetics, prenatal/neonatal, infectious diseases, and others.
The NGS sample preparation market segmentation (on the basis of end user) is segmented into hospitals and clinics, academic research institutes, pharmaceutical and biotechnology companies, and others.
Key Companies in the NGS sample preparation market
The key manufacturers who have been contributing significantly to the NGS sample preparation market include Agilent Technologies, Inc., Aurora Biomed Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Eppendorf AG, F. Hoffmann-La Roche AG, Hamilton Company, Illumina, Inc., New England Biolabs, Inc., Tecan Trading AG, Oxford Nanopore Technologies Limited, PerkinElmer Inc., Promega Corporation, QIAGEN N.V., Swift Biosciences Inc., Thermo Fisher Scientific, Inc., among others.
Executive Summary
1 Research Scope and Methodology
1.1 Scope of the Study
1.2 Research Methodology
1.3 Data Sources
1.4 Assumptions and Limitations
1.5 Data and Prediction Modelling

2 Market Overview
2.1 The Basic NGS Workflow
2.2 Global NGS Sample Preparation Market Scenario
3 Market Dynamics
3.1 Drivers
3.1.1 Short Term Driver
3.1.1.1 Rising Prevalence of Genetic Disorders
3.1.2 Current Drivers
3.1.2.1 Increasing Direct-to-Consumer Genetic Testing
3.1.2.2 Rising Prevalence of Infectious Diseases
3.1.3 Long Term Driver
3.1.3.1 Increasing Research Funding in the Field of Genomics
3.2 Restraints
3.2.1 Short Term Restraint
3.2.1.1 High Cost of Automated NGS Sample Preparation Instruments
3.2.2 Current Restraint
3.2.2.1 Lack of Advanced Genetic Testing Centers
3.2.3 Long Term Restraint
3.2.3.1 Stringent Regulatory Standards
3.3 Market Opportunities
3.3.1 Adoption of Automated NGS Sample Preparation in the Emerging Markets
3.3.2 Technological Advancements in NGS Sample Preparation
3.3.3 Opportunity (by Product)
3.3.3.1 Workstations
3.3.3.2 Consumables
3.3.4 Opportunity (by Application)
3.3.4.1 DNA Sequencing
3.3.4.2 Metagenomics
3.3.5 Opportunity (by Region)
3.3.5.1 North America
3.3.5.2 APAC
4 Automated NGS Sample Preparation Market: Industry Insights
4.1 Key Developments
4.1.1 Product Launch
4.1.2 Collaborations, Partnerships and Agreements:
4.1.3 Product Enhancements
4.1.4 Acquisitions
4.1.5 Business Expansions
4.2 Industry Trends
4.2.1 Preference for Automated NGS Sample Preparation Workstations Integrated with QC (Quality Control)
4.2.2 Growing Trend for the Preference of Customized Automated NGS Sample Preparation Platform
5 Next-Generation Sequencing Sample Preparation Market, End-User & Pricing Analysis
5.1 Satisfaction Level of Different Instruments (by Brand)
5.2 Pricing Analysis of Preferred Products– Step Wise (Sample Quantification, Library Preparation, Target Enrichment, Library Quantification)
5.3 Pricing Analysis - Accessories and Components
5.4 Pricing Analysis – Consumables
6 NGS Sample Preparation Market (by Product)
6.1 Automated Workstations
6.1.1 Open Systems
6.1.2 Closed Systems
6.2 Standalone Automation Instruments
6.2.1 Fragment Analyzer
6.2.2 Ultrasonicator/ Sonicator
6.2.3 DNA/RNA Shearing Instruments
6.2.4 Template Preparation Instruments
6.2.5 DNA Selection Instruments
6.2.6 Nucleic Acid Extraction/Isolation System
6.3 Consumables
6.3.1 Sample Extraction and Isolation Kits
6.3.2 Sample Purification Kits
6.3.3 Library Preparation Kits
6.3.3.1 DNA Library Preparation Kits
6.3.3.2 RNA Library Preparation Kits
6.3.3.3 FFPE DNA Kits
6.3.3.4 ChIP-Seq Library Preparation
6.3.3.5 Library Quantitation
6.3.3.6 Library Amplification
6.3.3.7 Library Preparation Accessories
6.3.4 Clean-up and Selection Kits
6.3.5 Target Enrichment Kits
6.3.6 Microbiome DNA Enrichment
6.3.7 Other Consumables
6.4 Accessories and Components
7 NGS Sample Preparation Market (by Workflow)
7.1 Sample Extraction/Isolation
7.2 Sample Quantification
7.3 Quality Control
7.4 Fragmentation
7.5 Library preparation
7.6 Target Enrichment
7.7 Library Quantification
7.8 Pooling
8 NGS Sample Preparation Market (by Therapeutic Area)
8.1 Oncology
8.2 Human Genetics/Population Genetics
8.3 Prenatal/Neonatal
8.4 Infectious Diseases
8.5 Other Therapeutic Areas
9 NGS Sample Preparation Market (by Application)
9.1 DNA Sequencing
9.2 Whole-Genome Sequencing
9.3 RNA Sequencing
9.4 Methylation Sequencing
9.5 Metagenomics
9.6 Single Cell Sequencing
9.7 Others
10 NGS Sample Preparation Market (by End-User)
10.1 Hospitals and Clinics
10.2 Academic and Research Institutes
10.3 Pharmaceutical and Biotechnology Companies
10.4 Other End-Users
11 NGS Sample Preparation Market (by Region)
11.1 Overview
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Netherlands
11.3.7 Russia
11.3.8 Rest-of-Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 Australia
11.4.4 India
11.4.5 Rest-of-Asia-Pacific
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest-of-Latin-America
11.6 Middle East and Africa
12 Competitive Landscape
12.1 Market Share Analysis
12.2 Product Benchmarking
12.3 Growth Share Analysis by End-User
12.4 Growth Share Analysis by Region
12.5 Growth Share Analysis by Product
13 Strategic Recommendations
13.1 Key Takeaways
13.2 Benchmarking Roche, Qiagen and Illumina Position in NGS Sample Preparation Market
13.3 Gap Analysis
13.4 Business Expansion Opportunity Mapping
13.4.1 By Product
13.4.2 By Region
13.5 Investment Opportunities
13.6 SWOT Analysis
13.7 Propitious Strategies to Succeed in NGS Sample Preparation Market
13.7.1 Optimizing Existing Products for Existing Customers
13.7.2 Expanding into Niche Applications
14 Company Profiles
14.1 Agilent Technologies
14.1.1 Company Overview
14.1.2 Role of Agilent Technologies in the Global NGS Sample Preparation Market
14.1.3 Financials
14.1.4 Key Insights about Financial Health of the Company
14.1.5 SWOT Analysis
14.2 Aurora Biomed Inc.
14.2.1 Company Overview
14.2.2 Role of Aurora Biomed Inc. in the Global NGS Sample Preparation Market
14.2.3 SWOT Analysis
14.3 Bio-Rad Laboratories, Inc.
14.3.1 Company Overview
14.3.2 Role of Bio-Rad Laboratories, Inc. in the Global NGS Sample Preparation Market
14.3.3 Financials
14.3.4 Key Insights about Financial Health of the Company
14.3.5 SWOT Analysis
14.4 Danaher Corporation
14.4.1 Company Overview
14.4.2 Role of Danaher Corporation in the Global NGS Sample Preparation Market
14.4.3 Financials
14.4.4 Key Insights about Financial Health of the Company
14.4.5 SWOT Analysis
14.5 Eppendorf AG
14.5.1 Company Overview
14.5.2 Role of Eppendorf AG in the NGS Sample Preparation Market
14.5.3 Financials
14.5.4 Key Insights about Financial Health of the Company
14.5.5 SWOT Analysis
14.6 F. Hoffmann-La Roche Ltd
14.6.1 Company Overview
14.6.2 Role of Roche in the Global NGS Sample Preparation Market
14.6.3 Financials
14.6.4 Key Insights about Financial Health of the Company
14.6.5 SWOT Analysis
14.7 Hamilton Company
14.7.1 Company Overview
14.7.2 Role of Hamilton Company in the global NGS Sample Preparation Market
14.7.3 SWOT Analysis
14.8 Illumina, Inc.
14.8.1 Company Overview
14.8.2 Role of Illumina, Inc. in the global NGS Sample Preparation Market
14.8.3 Financials
14.8.4 Key Insights about Financial Health of the Company
14.8.5 SWOT Analysis
14.9 New England Biolabs, Inc
14.9.1 Company Overview
14.9.2 Role of New England Biolabs, Inc. in the Global NGS Sample Preparation Market
14.9.3 SWOT Analysis
14.10 Oxford Nanopore Technologies Limited
14.10.1 Company Overview
14.10.2 Role of Oxford Nanopore Technologies Limited in the Global NGS Sample Preparation Market
14.10.3 SWOT Analysis
14.11 PerkinElmer, Inc.
14.11.1 Company Overview
14.11.2 Role of PerkinElmer, Inc. in the NGS Sample Preparation Market
14.11.3 Financials
14.11.4 SWOT Analysis
14.12 Promega Corporation
14.12.1 Company Overview
14.12.2 Role of Promega Corporation in the Global NGS Sample Preparation Market
14.12.3 SWOT Analysis
14.13 QIAGEN N.V.
14.13.1 Company Overview
14.13.2 Role of QIAGEN N.V. in the NGS Sample Preparation Market
14.13.3 Financials
14.13.4 Key Insights about Financial Health of the Company
14.13.5 SWOT Analysis
14.14 Swift Biosciences Inc.
14.14.1 Company Overview
14.14.2 Role of Swift Biosciences Inc. in the Global NGS Sample Preparation Market
14.14.3 SWOT Analysis
14.15 Tecan Group
14.15.1 Company Overview
14.15.2 Role of Tecan Group in the Global NGS Sample Preparation Market
14.15.3 Financials
14.15.4 Key Insights about Financial Health of the Company
14.15.5 SWOT Analysis
14.16 Thermo Fisher Scientific Inc.
14.16.1 Company Overview
14.16.2 Role of Thermo Fisher Scientific Inc. in the Global NGS Sample Preparation Market
14.16.3 Financials
14.16.4 Key Insights about Financial Health of the Company
14.16.5 SWOT Analysis
List of Tables
Table 5.1: Pricing Analysis of Market Available Consumables
Table 6.1: Global NGS Sample Preparation Market Size (by Product), $Million, 2018-2025
Table 13.1: Major Issues in Research Laboratories in the Asia-Pacific Region
Table 13.2: Funding Scenario
List of Figures
Figure 1: Impact of Market Drivers and Market Restraints on the Global NGS Sample Preparation Market
Figure 2: NGS Sample Preparation Market (by Product), 2018 vs 2025, $Million
Figure 3: NGS Sample Preparation Market (by Application), 2018 vs 2025, $Million
Figure 4: NGS Sample Preparation Market (by End-User), 2018 vs 2025, $Million
Figure 5: Global NGS Sample Preparation Market Snapshot
Figure 1.1: Global NGS Sample Preparation Market Segmentation
Figure 1.2: Global NGS Sample Preparation Market Research Methodology
Figure 1.3: Primary Research
Figure 1.4: Secondary Research
Figure 1.5: Data Triangulation
Figure 1.6: Bottom-Up Approach (Segment-Wise Analysis)
Figure 1.7: Top-Down Approach (Segment-Wise Analysis)
Figure 1.8: Assumptions and Limitations
Figure 1.9: Considered Factors for Data Prediction and Modelling
Figure 2.1: Global NGS Sample Preparation Market, 2018-2025
Figure 3.1: Market Dynamics of Global NGS Sample Preparation Market
Figure 3.2: People Suffering from CF (Cystic Fibrosis), 2002-2017:
Figure 3.3: Number of Deaths by Top 18 Infectious Diseases, 2015
Figure 3.4: China Healthcare Expenditure (% of GDP), 2010-2016:
Figure 4.1: Share of Key Developments and Strategies
Figure 4.2: Product Launches Share (by Company), 2016 – 2019
Figure 4.3: Collaborations, Partnerships, and Agreements Share (by Company), 2016 - 2019
Figure 4.4: Product Enhancement Share (by Company), 2016 - 2019
Figure 4.5: Acquisitions Share (by Company), 2016 - 2019
Figure 4.6: Business Expansions Share (by Company), 2016 - 2019
Figure 5.1: NGS Sample Preparation Customer Preference (by Major Brand) (N=36)
Figure 5.2: NGS Sample Preparation Customer Satisfaction Level (5 being the highest) (by Brand) (N=36)
Figure 6.1: NGS Sample Preparation Market (by Product), $Million, 2019 and 2025,
Figure 6.2: Automated Workstations Market, $Million, 2018-2025
Figure 6.3: Open System Workstations Market, $Million ,2018-2025
Figure 6.4: Closed System Workstations Market, $Million, 2018-2025
Figure 6.5: Automated Workstations Market, $Million, 2018-2025
Figure 6.6: Fragment Analyzer Market, $Million, 2018-2025
Figure 6.7: Ultrasonicator/ Sonicator Market, $Million, 2018-2025
Figure 6.8: DNA/RNA Shearing Instruments Market, $Million, 2018-2025
Figure 6.9: Template Preparation Instruments Market, $Million, 2018-2025
Figure 6.10: DNA Selection Instruments Market, $Million, 2018-2025
Figure 6.11: Nucleic Acid Extraction/Isolation System Market, $Million, 2018-2025
Figure 6.12: NGS Sample Preparation Consumables Market, $Million, 2018-2025
Figure 6.13: NGS Sample Extraction and Isolation Kits Market, $Million, 2018-2025
Figure 6.14: NGS Sample Purification Kits Market, $Million, 2018-2025
Figure 6.15: NGS Library Preparation Kits Market, $Million, 2018-2025
Figure 6.16: NGS DNA Library Preparation Kits Market, $Million, 2018-2025
Figure 6.17: NGS RNA Library Preparation Kits Market, $Million, 2018-2025
Figure 6.18: FFPE DNA Kits Market, $Million, 2018-2025
Figure 6.19: ChIP-Sequencing Library Preparation Market, $Million, 2018-2025
Figure 6.20: Library Quantitation Market,$Million, 2018-2025
Figure 6.21: Library Amplification Market, $Million, 2018-2025
Figure 6.22: Library Preparation Accessories Market, $Million, 2018-2025
Figure 6.23: NGS Clean-Up and Selection Kits Market, $Million, 2018-2025
Figure 6.24: Target Enrichment Market, $Million, 2018-2025
Figure 6.25: Microbiome DNA Enrichment Market, $Million, 2018-2025
Figure 6.26: Other Consumables Market, $Million, 2018-2025
Figure 6.27: NGS Sample Preparation Consumables Market, $Million, 2018-2025
Figure 7.1: NGS Sample Preparation Market (by Workflow), $Million, 2019 and 2025
Figure 7.2: Sample Extraction/Isolation Market, $Million, 2018-2025
Figure 7.3: Sample Quantification Market, $Million, 2018-2025
Figure 7.4: Quality Control Market, $Million, 2018-2025
Figure 7.5: Fragmentation Market, $Million, 2018-2025
Figure 7.6: Library Preparation Market, $Million, 2018-2025
Figure 7.7: Target Enrichment Market, $Million, 2018-2025
Figure 7.8: Library Quantification Market, $Million, 2018-2025
Figure 7.9: Sample Pooling Market, $Million, 2018-2025
Figure 8.1: NGS Sample Preparation Market (by Therapeutic Area), $Million, 2019 and 2025
Figure 8.2: NGS Oncology Sample Preparation Market, $Million, 2018-2025
Figure 8.3: NGS Human Genetics/Population Genetics Sample Preparation Market, $Million, 2018-2025
Figure 8.4: NGS Prenatal/Neonatal Sample Preparation Market, $Million, 2018-2025
Figure 8.5: NGS Prenatal/Neonatal Sample Preparation Market, $Million, 2018-2025
Figure 8.6: NGS Other Therapeutic Areas Sample Preparation Market, $Million, 2018-2025
Figure 9.1: NGS Sample Preparation Market (by Application), $Million, 2019 and 2025
Figure 9.2: NGS Sample Preparation Market for DNA Sequencing, $Million, 2018-2025
Figure 9.3: NGS Sample Preparation Market for Whole-Genome Sequencing, $Million , 2018-2025
Figure 9.4: NGS Sample Preparation Market for RNA Sequencing, $Million ,2018-2025
Figure 9.5: NGS Sample Preparation Market for Methylation Sequencing, $Million ,2018-2025
Figure 9.6: NGS Sample Preparation Market for Metagenomics, $Million ,2018-2025
Figure 9.7: NGS Sample Preparation Market for Single Cell Sequencing, $Million, 2018-2025
Figure 9.8: NGS Sample Preparation Market for Other Applications, $Million, 2018-2025
Figure 10.1: NGS Sample Preparation Market, By End-User, $Million, 2019 and 2025
Figure 10.2: NGS Sample Preparation Market for Hospital and Clinics, $Million, 2018-2025
Figure 10.3: NGS Sample Preparation Market for Academic and Research Institutes, $Million, 2018-2025
Figure 10.4: NGS Sample Preparation Market for Pharmaceutical & Biotechnology Companies, $Million, 2018-2025
Figure 10.5: NGS Sample Preparation Market for Other End-Users, $Million, 2018-2025
Figure 11.1: NGS Sample Preparation Market (by Region), $Million, 2019 and 2025
Figure 11.2: NGS Sample Preparation Market (by Region), $Million, 2018-2025
Figure 11.3: North America: Market Dynamics
Figure 11.4: North America NGS Sample Preparation Market (by Country), $Million, 2018-2025
Figure 11.5: U.S. NGS Sample Preparation Market, $Million, 2018-2025
Figure 11.6: U.S. NGS Sample Preparation Market, by Product, $Million, 2018-2025
Figure 11.7: U.S. NGS Sample Preparation Market, by Automated Workstation, $Million, 2018-2025
Figure 11.8: U.S. NGS Sample Preparation Market, by Instrument, $Million, 2018-2025
Figure 11.9: U.S. NGS Sample Preparation Market, by Consumables, $Million, 2018-2025
Figure 11.10: Canada NGS Sample Preparation Market, $Million, 2018-2025
Figure 11.11: Europe: Market Dynamics
Figure 11.12: Europe NGS Sample Preparation Market, By Country, $Million, 2018-2025
Figure 11.13: Germany NGS Sample Preparation Market, $Million, 2018-2025
Figure 11.14: France NGS Sample Preparation Market, $Million, 2018-2025
Figure 11.15: U.K. NGS Sample Preparation Market, $Million, 2018-2025
Figure 11.16: Italy NGS Sample Preparation Market, $Million, 2018-2025
Figure 11.17: Spain NGS Sample Preparation Market, $Million, 2018-2025
Figure 11.18: The Netherlands NGS Sample Preparation Market, $Million, 2018-2025
Figure 11.19: Russia NGS Sample Preparation Market, $Million, 2018-2025
Figure 11.20: Rest-of-Europe NGS Sample Preparation Market, $Million, 2018-2025
Figure 11.21: APAC: Market Dynamics
Figure 11.22: Asia-Pacific NGS Sample Preparation Market, By Country, $Million, 2018-2025
Figure 11.23: China NGS Sample Preparation Market, $Million, 2018-2025
Figure 11.24: Japan NGS Sample Preparation Market, $Million, 2018-2025
Figure 11.25: Australia NGS Sample Preparation Market, $Million, 2018-2025
Figure 11.26: India NGS Sample Preparation Market, $Million, 2018-2025
Figure 11.27: Rest-of-APAC NGS Sample Preparation Market, $Million, 2018-2025
Figure 11.28: Latin America: Market Dynamics
Figure 11.29: Latin America NGS Sample Preparation Market, By Country, $Million, 2018-2025
Figure 11.30: Brazil NGS Sample Preparation Market, $Million, 2018-2025
Figure 11.31: Mexico NGS Sample Preparation Market, $Million, 2018-2025
Figure 11.32: Rest-of-Latin-America NGS Sample Preparation Market, $Million, 2018-2025
Figure 11.33: Middle East and Africa: Market Dynamics
Figure 11.34: Middle East and Africa NGS Sample Preparation Market, $Million, 2018-2025
Figure 12.1: Market Share Analysis for the Global NGS Sample Preparation Market, 2018
Figure 12.2: NGS Sample Preparation Heat Map (by Product)
Figure 12.3: Growth Share Matrix for Global NGS Sample Preparation Market (by End User), 2018
Figure 12.4: Growth Share Matrix for Global NGS Sample Preparation Market (by Region), 2018
Figure 12.5: Growth Share Matrix for Global NGS Sample Preparation Market (by Product), 2018
Figure 13.1: Growth Share Matrix for Global NGS Sample Preparation Market (Top 5), 2018
Figure 13.2: Business Expansion Opportunity Mapping (by Product)
Figure 13.3: Business Expansion Opportunity Mapping (by Region)
Figure 13.4: NGS Sample Preparation Market: SWOT Analysis
Figure 14.1: Agilent Technologies: Product Portfolio
Figure 14.2: Agilent Technologies: Overall Financials, 2016-2018
Figure 14.3: Agilent Technologies: Revenue (by Segment), 2016-2018
Figure 14.4: Agilent Technologies: Revenue (by Region), 2016-2018
Figure 14.5: Agilent Technologies: R&D Expenditure, 2016-2018
Figure 14.6: Agilent Technologies: SWOT Analysis
Figure 14.7: Aurora Biomed Inc.: Overall Product Portfolio
Figure 14.8: Aurora Biomed Inc.: SWOT Analysis
Figure 14.9: Bio-Rad Laboratories, Inc.: Product Offerings
Figure 14.10: Bio-Rad Laboratories, Inc.: Overall Financials, 2016-2018
Figure 14.11: Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2016-2018
Figure 14.12: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2016-2018
Figure 14.13: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2016-2018
Figure 14.14: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 14.15: Danaher Corporation: Product Portfolio
Figure 14.16: Danaher Corporation: Overall Financials, 2016-2018
Figure 14.17: Danaher Corporation: Revenue (by Business Segment), 2016-2018
Figure 14.18: Danaher Corporation: Revenue (by Region), 2016-2018
Figure 14.19: Danaher Corporation: R&D Expenditure, 2016-2018
Figure 14.20: Danaher Corporation: SWOT Analysis
Figure 14.21: Eppendorf AG: Overall Product Portfolio
Figure 14.22: Eppendorf AG: Overall Financials, 2016-2018
Figure 14.23: Eppendorf AG: Revenue (by Region), 2016-2018
Figure 14.24: Eppendorf AG: R&D Expenditure, 2016-2018
Figure 14.25: Eppendorf AG: SWOT Analysis
Figure 14.26: F. Hoffmann-La Roche AG: Product Offerings
Figure 14.27: F. Hoffmann-La Roche Ltd: Overall Financials, 2016-2018
Figure 14.28: F. Hoffmann-La Roche Ltd: Sales (by Segment), 2016-2018
Figure 14.29: F. Hoffmann-La Roche Ltd: Sales (by Region), 2016-2018
Figure 14.30: F. Hoffmann-La Roche Ltd: R&D Expenditure, 2016-2018
Figure 14.31: F. Hoffmann-La Roche Ltd: SWOT Analysis
Figure 14.32: Hamilton Company: Overall Product Portfolio
Figure 14.33: Hamilton Company: SWOT Analysis
Figure 14.34: Product Portfolio: Illumina, Inc.
Figure 14.35: Illumina, Inc.: Overall Financials, 2016-2018
Figure 14.36: Illumina, Inc.: Revenue (by Segment), 2016-2018
Figure 14.37: Illumina, Inc.: Revenue (by Region), 2016-2018
Figure 14.38: Illumina, Inc.: R&D Expenditure, 2016-2018
Figure 14.39: Illumina, Inc.: SWOT Analysis
Figure 14.40: New England Biolabs, Inc: Product Offerings
Figure 14.41: New England Biolabs, Inc.: SWOT Analysis
Figure 14.42: Oxford Nanopore Technologies Limited: Product Offerings
Figure 14.43: Oxford Nanopore Technologies Limited: SWOT Analysis
Figure 14.44: PerkinElmer, Inc.: Product Portfolio
Figure 14.45: Perkin Elmer, Inc.: Overall Financials, (2016-2018)
Figure 14.46: Perkin Elmer, Inc.: Revenue (by Business Segment), 2016-2018
Figure 14.47: Perkin Elmer, Inc.: Revenue (by Region), 2016-2018
Figure 17.48: PerkinElmer, Inc.: R&D Expenditure, 2016-2018
Figure 14.49: PerkinElmer, Inc.: SWOT Analysis
Figure 14.50: Promega Corporation: Overall Product Portfolio
Figure 14.51: Promega Corporation: SWOT Analysis
Figure 14.52: QIAGEN N.V.: Overall Product Portfolio
Figure 14.53: QIAGEN N.V.: Overall Financials, 2016-2018
Figure 14.54: QIAGEN N.V.: Revenue (by Segment), 2016-2018
Figure 14.55: QIAGEN N.V.: Revenue (by Region), 2016-2018
Figure 14.56: QIAGEN N.V.: R&D Expenditure, 2016-2018
Figure 14.57: QIAGEN N.V.: SWOT Analysis
Figure 14.58: Swift Biosciences Inc.: Overall Product Portfolio
Figure 14.59: Swift Biosciences Inc.: SWOT Analysis
Figure 14.60: Product Portfolio: Tecan Group
Figure 14.61: Tecan Group: Overall Financials, 2016-2018
Figure 14.62: Tecan Group Revenue (by Segment), 2016-2018
Figure 14.63: Tecan Group: Revenue (by Region), 2016-2018
Figure 14.64: Tecan Group: R&D Expenditure, 2016-2018
Figure 14.65: Tecan Group: SWOT Analysis
Figure 14.66: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 14.67: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
Figure 14.68: Thermo Fisher Scientific Inc.: Revenue (by Segment), 2016-2018
Figure 14.69: Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
Figure 14.70: Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
Figure 14.71: Thermo Fisher Scientific Inc.: SWOT Analysis
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Netherlands
Russia
Rest-of-Europe
Asia-Pacific
China
Japan
Australia
India
Rest-of-Asia-Pacific
Latin America
Brazil
Mexico
Rest-of-Latin-America
Middle East and Africa
Global NGS Sample Preparation Market, NGS Sample Preparation Market Report, NGS Sample Preparation Report, NGS Sample Preparation Industry, NGS Sample Preparation Market Size, NGS Sample Preparation Market Share, NGS Sample Preparation Market Forecast, NGS Sample Preparation Market Growth, NGS Sample Preparation Market opportunity, NGS Sample Preparation Industry size, NGS Sample Preparation Market Outlook, NGS Sample Preparation Market Trends, NGS Sample Preparation Market Segments, NGS Sample Preparation Market Drivers, NGS Sample Preparation Market Competitive Landscape, NGS Sample Preparation Market Industry Insights, NGS Sample Preparation Market by Type, NGS Sample Preparation Market by Region, NGS Sample Preparation Market by End Users, NGS Sample Preparation Industry Outlook, NGS Sample Preparation Industry Trends, NGS Sample Preparation Industry Share, NGS Sample Preparation Industry Forecast
According to the latest report by BIS Research, titled ‘Global NGS Sample Preparation Market – Analysis and Forecast (2019-2025)’, the global NGS sample preparation market to grow at a significant CAGR of 15.54% during the forecast period, 2019-2025. Growth in this market is driven by the rising prevalence of genetic disorders and infectious diseases, increasing direct-to-consumer genetic testing, and increasing research in the field of genomics. The massive scope for adoption of automated NGS sample preparation in the emerging markets and technological advancements in automated NGS sample preparation are also expected to provide growth opportunities for players in the market. On the other hand, cost constraints pertaining to automated NGS sample preparation affecting adoption, lack of high complexity genetic testing centers, and regulatory uncertainty pertaining to automated sample preparation are expected to limit market growth in the coming years.
The North America NGS sample preparation market currently holds a dominating 42.10% share of the global NGS sample preparation market. The growth in this region can be attributed to the presence of prominent market players in the U.S., and growing adoption of next generation sequencing in research, diagnostics, and synthetic biology. The growing prevalence of infectious diseases, genetic disorders, and chronic diseases, such as breast cancer, lung cancer, melanoma, and leukemia, and development of novel library preparation kits are some of the factors that also lead to the dominance of North America in the global NGS sample preparation market.However, the Asia-Pacific market is expected to grow in the forthcoming period due to several new and advanced sequencing techniques such as whole genome sequence and single cell sequencing being implemented to help enable researchers utilize disease-specific DNA and RNA information to improvize therapeutic and diagnostic research in the Asia-Pacific region.
The global NGS sample preparation market has a long way to go with large as well as small players operating at the global and regional level. The prominent players in this market include Agilent Technologies, Inc., Aurora Biomed Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Eppendorf AG, F. Hoffmann-La Roche AG, Hamilton Company, Illumina, Inc., New England Biolabs, Inc., Tecan Trading AG, Oxford Nanopore Technologies Limited, PerkinElmer Inc., Promega Corporation, QIAGEN N.V., Swift Biosciences Inc., Thermo Fisher Scientific, Inc., among others.
Agilent Technologies
Aurora Biomed Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
Eppendorf AG
F. Hoffmann-La Roche Ltd
Hamilton Company
Illumina, Inc.
New England Biolabs, Inc.
Oxford Nanopore Technologies Limited
PerkinElmer, Inc.
Promega Corporation
QIAGEN N.V.
Swift Biosciences Inc.
Tecan Group
Thermo Fisher Scientific Inc.
Global NGS Sample Preparation Market to Grow at a CAGR of 15.54% from 2019-2025